CLINICAL_TRIALS
trial_result
· 2021-05-07
Clinical Trial Update: Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler [Phase 2]
Summary
A Phase 2 study evaluating five doses of RPL554 versus placebo in COPD patients via a dry powder inhaler has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Verona Pharma plc | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2021-05-07